A computer-assisted sperm analysis (CASA) system was used to examine the motion of epididymal spermatozoa derived from cyclophosphamide (CP)-treated male rats. Male rats were orally dosed daily for 1 week with 20 mg/kg of CP. Males were euthanized or were mated 3 times with untreated females at 1 day, 3 weeks, and 8 weeks after the final treatment. Significant decreases in testicular and epididymal weights and epididymal sperm counts of the treated animals were noted after 8-week recovery. Histopathological morphometry of the testis revealed minimal damage to spermatogonia at 1 day after the final treatment and to spermatocytes after 3-week recovery in the CP-treated group. On Caesarian section, increased post-implantation losses were found in females mated with CP-treated males in matings starting 1 day and 3 weeks after the final treatment. On the other hand, none of the sperm motion parameters of treated males derived from the CASA system exhibited significant changes at any time points, although the spermatozoa of treated males at 1 day and 3 weeks after the final treatment were damaged at the DNA level, and the spermatozoa of males after 8-week recovery had been the target cells of CP when they were spermatogonia in the testis. It was thus found that damaged spermatozoa could exhibit no changes on their motion when the damage was confined to the nuclei, and that the effect of CP on sperm nuclei was reversible.
INTRODUCTION
Cyclophosphamide (CP) is widely used in cancer chemotherapy as an immunosuppressant. The activated metabolites of CP are alkylating agents that cause cross-linking of DNA strands and interference with normal cell division in all rapidly proliferating tissues. Thus, CP also has many toxic properties that induce side effects. Alteration of male fertility is one of the serious side effects of CP. Adult male patients treated with CP exhibited an increased incidence of oligospermia or azospermia (Fairley et al., 1972; Qureshi et al., 1972) . Many studies using experimental animals have also suggested that CP affects male reproductive systems. Very high doses of CP killed spermatogonia even when administered in a single injection (Lu and Meistrich, 1979) . Meanwhile, chronic low-dose CP treatment affected mature spermatozoal nuclei without any remarkable histopathological damage to male reproductive organs, resulting in increased loss of pregnancy outcomes (Trasler et al., 1986) . Therefore, CP exerts its toxic effects on male germ cells in different stages during the course of sperm development and maturation. In the rat, one of the most characteristic effects of CP in the male reproductive systems is on post-testicular spermatozoa. Short-term CP treatment resulted in increased post-implantation loss in untreated female rats copulated with treated males (Qiu et al., 1992) . This suggested that CP may alter the quality of mature spermatozoal nuclei in the epididymis, resulting in post-implantation embryonic death. Although the mechanism by which CP affects mature spermatozoa
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has not been fully elucidated, Qiu et al. (1995) found that long-term CP treatment affected the spermatozoal potential for decondensation, a phenomenon that occurs in the oocyte following fertilization. Probably fertilized ova fused with CP-exposed sperms may have failed to develop normal nuclei for their lives as embryos. In addition, Trasler et al. (1988) observed slightly increased incidence of flagellar abnormalities in spermatozoa of CP-treated male rats even after a sacrifice interval of up to 9 weeks. These results indicated that CP altered the quality of spermatozoa. However, other studies reported no effects of CP on sperm motion when examined manually (Qiu et al., 1992; Higuchi et al., 1997) . It may be possible that, in these studies, CP actually had subtle effects on sperm motion parameters not detectable by the manual method of counting motile and non-motile sperm.
In the current toxicological methods, in order to detect a certain effect of CP on spermatozoa, the most efficient method probably is to examine the fertility of exposed males by mating with untreated females (Higuchi et al., 1995) . On the other hand, histopathological examination of the testis and sperm analysis have recently been recognized as the most sensitive methods for detection of male reproductive disorders (Takayama et al., 1995) . Among sperm analyzing techniques, the computer-assisted sperm analysis (CASA) system is becoming more popular, especially for sperm motion analysis, following the consensus paper on the methodology for measurements of rat sperm motion published by many users (Chapin et al., 1992) . The CASA system provides more objective and detailed data on sperm motion parameters than those yielded by conventional counting of motile sperm in visual fields microscopically. Since the manual method revealed no evidence of damage by CP to sperm motion in previous studies (Qiu et al., 1992; Higuchi et al., 1997) , the present study was conducted to accurately determine, using the CASA system, whether CP affects sperm motion parameters.
MATERIALS AND METHODS

Animals
Adult Sprague-Dawley male and female rats (Crj: CD) were purchased from Charles River, Ltd., Japan. Animals were maintained on a 12L:12D cycle with food and water provided ad libitum. The animal room was air-conditioned with 10-15 air changes per hr, with a controlled temperature and relative humidity of 24 2 and 40-70%, respectively. Both male and female rats were kept for at least one week for acclimatization, and then used in this study.
Experimental design 1. Treatment of male rats
After the acclimatization period, males (9 weeks old) were randomly assigned to the control or CP-treated groups. Male rats were given saline (control) or CP (Lot No.26H0473, Sigma Chemical Co., St. Louis, MO, USA), at a dosage of 20 mg/kg, by gavage (5 ml/kg) daily for 1 week. The dosage of 20 mg/kg was selected, because our previous study (Higuchi et al., 1997) proved that 40 mg/kg CP treatment for 1 week caused deaths in approximately half of the males within 2 weeks after cessation of treatment. Thus, in the present study, the effects of CP on spermatogenesis in the testis were expected to be weaker than those in the previous study.
The test material solution was prepared daily by dissolving CP in saline and administered within 3 hr of preparation.
Males were observed at least once a day for mortality and clinical signs, and body weights were measured weekly throughout the study.
Sperm analysis and testicular histopathology
Thirty males in each group were euthanized by CO2 asphyxiation, including 10 each at 1 day, 3 weeks and 8 weeks after the 1-week treatment period. The testes and epididymides were removed and weighed. The right organs were homogenized and sonicated with 10 ml water (for the testis), or with 5 ml water (for the epididymis), and sperm head counts were recorded according to the method described by Meistrich (1989) .
The motion parameters for sperm collected from each male were analyzed using the CASA system according to the following method. One droplet of leaked sperm was collected from a puncture of the ductus epididymis at the distal end of the cauda epididymis, and introduced into 2 ml sperm suspension media [medium 199 with Hank's salts and L-glutamine (Gibco, Grand Island, NY, USA) supplemented with 1.0% w/v bovine serum albumin (Intergen Co., Purchase, NY, USA)] maintained at 37 . The sperm suspension was placed at 37 for 5 min so that sperm could diffuse completely in the media, and an aliquot of the suspension was drawn by capillary action into a pre-warmed glass cannula with a depth of 100 m (VitroCom Inc., Mt. Lakes, NJ, USA). The sample was measured using a Hamilton Thorne Integrated Visual Optical System semen analyzer (HTM-IVOS; Hamilton Thorn Research, Inc., Beverly, MA, USA) with software version 10 by setting the cannula in the sample chamber of the analyzer. A total of approximately 200 sperms were analyzed in each sample. The machine settings used in this study are listed in Table 1 . We modified the set-up values to achieve appropriate analysis of the rat sperm sample, and proved that the system with the settings used in this study can detect effects on sperm motion (data not shown), usingchlorohydrin, an antifertility agent known to inhibit sperm motility (Toth et al., 1989) .
The following sperm motion parameters were determined by HTM-IVOS: % motile (Motility), % progressively motile (Progressive), straight line velocity (VSL), curvilinear velocity (VCL), average path velocity (VAP), the amplitude of lateral head displacement (ALH), beat cross frequency (BCF), straightness (STR), and linearity (LIN). All these parameters, as well as other quantitative data, are expressed as means SD.
The left testis from each male was fixed with Bouin's solution for 1 day, and then stored in 10% neutral-buffered formalin. After a few weeks, 5 stored testes randomly selected from the 10 samples in each group were embedded in paraffin, sectioned, stained with H&E and PAS-H, and examined histopathologically for spermatogenesis.
Quantitative evaluation of spermatogenic cells in seminiferous tubules was performed using the simplified morphological method described by Matsui et al. (1995) . Among those exhibiting a round shape, four seminiferous tubules each for four spermatogenic stages (stages II-III, V, VII, and XII) were randomly selected, and the numbers of seminiferous epithelia were counted in each cross section of the tubule. The cell types were categorized into spermatogonia, preleptotene spermatocytes, zygotene spermatocytes, pachytene spermatocytes, round spermatids, and Sertoli cells. Then the ratios of each type of spermatogenic cells to Sertoli cells per cross section of a seminiferous tubule were calculated as measures of the populations of male germ cells.
Study of male fertility and pregnancy outcome
Another 10 CP-treated male rats and 10 control male rats were examined for fertility. Each male rat in each group was allowed to mate overnight with a healthy untreated virgin female rat (10 weeks old) in the 3 mating trials beginning at 1 day, 3 weeks and 8 weeks after the final treatment. On the morning after each mating, successful copulation was confirmed by the presence of spermatozoa in the vaginal smear from the females. The day when spermatozoa were found in the vagina was designated as Day 0 of gestation for the mated females. The mating trials continued for up to a maximum of 10 days or until each male had impregnated the untreated female partner. On Day 13 of gestation, the females were euthanized by CO2 asphyxiation, and then Caesarian-sectioned. The ovaries were removed and the number of corpora lutea was recorded. The uteri were opened and the numbers of implantations, resorptions and live fetuses were determined. These parameters are expressed as means SD. Implantation efficiency was calculated as the ratio of the number of implantations to the number of corpora lutea in each female. Post-implantation loss was determined as the percentage of the number of resorptions to the number of implantations.
Statistical analysis
All quantitative data derived from this study were analyzed statistically. The data were initially tested for homogeneity of variance by the F-test (Snedecor and Cochran, 1967) . When variances were homogeneous, the data were statistically analyzed using Student's ttest (Snedecor and Cochran, 1967) , and when variances were heterogeneous, Aspin-Welch's t-test (Snedecor and Cochran, 1967) was performed. Statistical significance was tested for at 5 % and 1 % levels. These set-up values were shown to be optimal acquisition parameters for HTM-IVOS for sperm samples which were prepared and analyzed in our laboratory.
RESULTS
Body weights, organ weights, and sperm counts
No animals were found dead during the study. Males exposed to CP and terminated at 1 day, 3 weeks, or 8 weeks after the final treatment had significantly lower body weights than those in the control group. The absolute weights of testes and epididymides of CPtreated males after 8-week recovery were slightly but significantly lower than those of the control animals. Relative testicular weight at 1 day after the final treatment and relative epididymal weight after 3-week recovery were significantly increased in the CP-treated group, but both of the changes were due to the lower body weights of CP-treated animals.
After 8-week recovery, the epididymal sperm head counts were significantly lower in the CP-treated group than those in the control animals, but no significant difference between the control and CP-treated groups was observed at any other time points (Table 2) .
Sperm motion parameters
The results of analysis of sperm motion parameters determined by HTM-IVOS are summarized in Table 3 . Motility data from 3 males (one each in the control and CP-treated groups at 1 day after the final treatment, and the other in the control group with 3-week recovery) were excluded, because these animals only had non-motile sperm, which exhibited morphological disconnection of head and tail.
Almost all of the sperm motion parameters in the control group determined by HTM-IVOS appeared to be comparable throughout the course of this study. The CP-treated group exhibited no toxic effects on sperm motion parameters at any time point compared with the control group. Although a significantly lower percentage of motile sperm was noted in the CP-treated group at 3 weeks after cessation of treatment, this significance appeared to be due to the comparatively higher value in the control group. The significant differences noted in the CP-treated group on STR at 1 day after the final treatment and on BCF after 3-week recovery were not considered treatment-related effects because of the slight magnitude of the changes and isolated occurrences.
Quantitative morphometry of spermatogenic cells in the testis
While no substantial changes in the testis were found in the histopathological examinations at any time point after cessation of treatment, quantitative morphometry revealed that the dosage of 20 mg/kg CP had a minimal effect on the spermatogenic cells in the testis, which could not have been detected otherwise.
At 1 day after the treatment period, the numbers of spermatogonia in stages II-III and V in the CP-treated males were significantly lower than those in control rats (Fig. 1) . The populations of the other types of spermatogenic cells were unchanged.
After 3-week recovery, the numbers of pachytene spermatocytes in stages VII and XII, and the number of round spermatids in stage II-III in the CP-treated males were significantly decreased compared with those in control animals (Fig. 2) . The number of spermatogonia in the CP-treated males, which was decreased at 1 day after the final treatment, was comparable to that in control males in all spermatogenic stages examined.
After 8-week recovery, numbers of spermatogenic cells in some stages were incidentally decreased in CPtreated males (Fig. 3 ). These were not considered as treatment-related effects, because no changes in numbers of spermatogenic cells were observed at the same time point in our previous study with a dosage of 40 mg/kg CP (Higuchi et al., 1997) .
Fertility of males and Caesarian section data
Almost all of the male rats in the control and CPtreated groups mated successfully with untreated female partners, and fertility of males was not affected by CP treatment. The data derived from Caesarian section on Day 13 of gestation of the untreated pregnant females are shown in Table 4 . Increased post-implantation losses, accompanied by decreased numbers of live embryos, were noted in females mated at 1 day and 3 weeks after cessation of paternal treatment. Significantly decreased number of corpora lutea and implantations were noted at 1 day and 3 weeks after the final treatment. In addition, slightly decreased implantation efficiency was observed at 3 weeks after cessation of paternal treatment. The implantation efficiency and post-implantation loss in females mated 8 weeks after cessation of paternal treatment were comparable to those in females mated with control rats.
DISCUSSION
The CASA system is considered useful for quantitative sperm motion analysis, and it is thus expected that objective evaluations of effects of chemicals on sperm motion can be obtained from the system. Slott et al. (1990) Table 2 . Reproductive parameters obtained at 1 day, 3 weeks, and 8 weeks after the treatment period. changes in rat sperm velocity, and urged the usefulness of this technology in male reproductive toxicology. In the present study, HTM-IVOS, one of the popular CASA systems, was employed to obtain objective quantitative data on sperm motion of CP-exposed animals at various time points in order to determine whether CP affects the sperm motion. This is the first report to systematically demonstrate that CP treatment to male rats causes no effects on epididymal sperm motion, by using the CASA system. Because post-implantation loss was remarkably increased in the untreated females mated with CP-treated males at 1 day or 3 weeks after the final treatment, it was suggested that 1-week treatment of CP at the dosage level of 20 mg/kg had toxic effects in semen. According to Qiu et al. (1992) , CP acts on spermatozoa in the caput and corpus epididymis and induces significantly increased postimplantation loss in the untreated female partner. Therefore, it was indicated that the spermatozoa, or at least their nuclei, derived from CPtreated male rats in this study were also damaged. In addition, it was possible that 20 mg/kg CP treatment induced morphological changes in the midpiece region of a part of spermatozoa, subtly altering sperm motion parameters, since structural abnormalities of the rat sperm flagella midpieces were induced by CP treatment at dosages of 5.1 or 6.8 mg/kg for up to 9 weeks (Trasler et al., 1988) . Thus, it seems to be natural to suppose that CP has effects on sperm motion. In the present study, however, analysis with the CASA system revealed that CP affected no sperm motion parameters at any time points after cessation of treatment. This Table 3 . Sperm motion parameters determined by HTM-IVOS at 1 day, 3 weeks, and 8 weeks after the treatment period.
1 day after the treatment period 3 weeks after the treatment period 8 weeks after the treatment period finding reinforced those of previous studies (Qiu et al., 1992; Higuchi et al., 1997) that reported no effects on sperm motion in rats treated with CP by manual counting of motile sperm. Therefore, it was concluded that CP did not affect any sperm motion parameters, even though CP caused a certain change to the flagellar structure. Furthermore, it was demonstrated that damaged sperm could exhibit no change in motion when their nuclei are affected. Spermatogonia are also target cells of CP in the male reproductive system. Regarding the rat sperm development and maturation, it would be expected that CP-exposed spermatogonia first appeared in the cauda epididymis at the end of the 8-week recovery period, after spermatogonia matured into spermatozoa. In the present study, spermatozoa, which had been the target cells when exposure occurred, exhibited no changes in sperm motion parameters after 8-week recovery, and also no changes were found in Caesarian section data of untreated females mated with CP-treated males after 8-week recovery. Thus, it was concluded that spermatogonia surviving CP exposure had normal ability to become mature spermatozoa. The effect of CP on sperm nuclei was considered to be reversible.
Decreased number of corpora lutea, implantations and implantation efficiency were observed in the untreated females mated with CP-treated males at 1 day and/or 3 weeks after the final treatment. These values were approximately the lower limits of, or less than our historical control data of the same strain. According to Robaire and Hales (1994) , CP and/or its metabolites was excreted in the seminal fluid of the treated male and transmitted to the untreated female partner, where it was absorbed across the female genital tracts. Thus, it was possible that CP administered to males affected ovulation and/or implantation of the female partners via semen which were deposited into the vagina during their intercourses.
The dosage level of 20 mg/kg CP affected spermatogonia in the testes of CP-exposed male rats, but to such a small extent that changes could only be detected by histopathological morphometry. In our previous study with histopathological examination on the testis of CP-treated male rats (Higuchi et al., 1997) , 40 mg/kg CP treatment for 1 week reduced the number of spermatogonia, subsequently caused remarkable changes such as atrophy of or giant cells in seminiferous tubules, and resulted in decreased numbers of epididymal sperm heads. Slight but similar histopathological findings appeared in the testis of male rats in the present study. Furthermore, the toxic effects of CP on organ weights and sperm head counts in the testis and epididymis were also weaker than those observed in our previous study, but similar findings were obtained for these parameters at termination after 8-week recovery, that is, decreased testicular or epididymal weights and decreased epididymal sperm counts. Therefore, it was demonstrated that 20 mg/kg of CP induced the minimal effects in the testis without any substantial lesions, following the slight changes in the weights of male reproductive organs and the sperm counts.
In conclusion, our findings prove that CP treatment affects no sperm motion parameters, with the CASA system. Thus, sperm motion parameters are not always altered when spermatozoa are toxically damaged. Because the development and maturation of the sperm and acquisition of critical functional characteristics are highly regulated by the biochemical environments in the testis and epididymis, perturbation of this balance may produce alterations in sperm properties such as motility. Toxicological studies on the male reproductive effects of chemical exposure often assess the motion parameters of epididymal sperm or sperm in semen as an indicator for reproductive function. However, based upon the results of the present study, it should be noted that sperm motion analysis does not always indicate the quality or maturity of spermatozoa in such a case as CP.
